ArticleVaccines2021

A Quantitative Benefit-Risk Analysis of ChAdOx1 nCoV-19 Vaccine among People under 60 in Italy.

Raffaele Palladino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.